Literature DB >> 10349223

When to be skeptical of negative studies: pitfalls in evaluating occupational risks using population-based case-control studies.

S W Hu1, I Hertz-Picciotto, J Siemiatycki.   

Abstract

This study investigated arsenic and lung cancer incidence in a community setting in the Montreal area. Job histories and sociodemographic factors were collected by interview from 857 lung cancer cases, 533 general population controls, and 1,360 controls with other cancers. Chemist-hygienists assessed each subject's life-time occupational exposure to 294 substances. Logistic regressions yielded arsenic/lung cancer odds ratios of 1.1 (95% confidence interval = 0.60, 1.7) based on cancer controls, and 0.82 (95% confidence interval = 0.41, 1.6) based on population controls. Risk did not rise with increasing level or probability of exposure. Worksite studies consistently show lung carcinogenicity from arsenic. Since confounding from other chemicals was well controlled, the most likely explanation is substantially lower exposures than in previous studies. The lack of association in this study demonstrates the need for caution in interpreting negative findings from population-based case-control studies, particularly when exposures are low or rare, as well as the difficulty in generating hypotheses from such studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349223      PMCID: PMC6979628     

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  21 in total

1.  Relation of arsenic exposure to lung cancer among tin miners in Yunnan Province, China.

Authors:  P R Taylor; Y L Qiao; A Schatzkin; S X Yao; J Lubin; B L Mao; J Y Rao; M McAdams; X Z Xuan; J Y Li
Journal:  Br J Ind Med       Date:  1989-12

2.  Associations between several sites of cancer and nine organic dusts: results from an hypothesis-generating case-control study in Montreal, 1979-1983.

Authors:  J Siemiatycki; L Richardson; M Gérin; M Goldberg; R Dewar; M Désy; S Campbell; S Wacholder
Journal:  Am J Epidemiol       Date:  1986-02       Impact factor: 4.897

3.  Resolving discrepancies among studies: the influence of dose on effect size.

Authors:  I Hertz-Picciotto; R R Neutra
Journal:  Epidemiology       Date:  1994-03       Impact factor: 4.822

Review 4.  Observations on the dose-response curve for arsenic exposure and lung cancer.

Authors:  I Hertz-Picciotto; A H Smith
Journal:  Scand J Work Environ Health       Date:  1993-08       Impact factor: 5.024

5.  Arsenic and respiratory cancer in humans: follow-up of copper smelter employees in Montana.

Authors:  A Lee-Feldstein
Journal:  J Natl Cancer Inst       Date:  1983-04       Impact factor: 13.506

6.  Arsenic exposure, smoking, and lung cancer in smelter workers--a case-control study.

Authors:  L Järup; G Pershagen
Journal:  Am J Epidemiol       Date:  1991-09-15       Impact factor: 4.897

7.  Cancer among workers exposed to arsenic and other substances in a copper smelter.

Authors:  P E Enterline; G M Marsh
Journal:  Am J Epidemiol       Date:  1982-12       Impact factor: 4.897

8.  Discovering carcinogens in the occupational environment. Methods of data collection and analysis of a large case-referent monitoring system.

Authors:  J Siemiatycki; S Wacholder; L Richardson; R Dewar; M Gérin
Journal:  Scand J Work Environ Health       Date:  1987-12       Impact factor: 5.024

9.  Associations between several sites of cancer and ten types of exhaust and combustion products. Results from a case-referent study in Montreal.

Authors:  J Siemiatycki; M Gérin; P Stewart; L Nadon; R Dewar; L Richardson
Journal:  Scand J Work Environ Health       Date:  1988-04       Impact factor: 5.024

Review 10.  Cancer risks from arsenic in drinking water.

Authors:  A H Smith; C Hopenhayn-Rich; M N Bates; H M Goeden; I Hertz-Picciotto; H M Duggan; R Wood; M J Kosnett; M T Smith
Journal:  Environ Health Perspect       Date:  1992-07       Impact factor: 9.031

View more
  2 in total

1.  Adverse effects of observational studies when examining adverse outcomes of drugs: case-control studies with low prevalence of exposure.

Authors:  Peter C Austin; Muhammad Mamdani; Ivan J Williams
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Gliomas and farm pesticide exposure in women: the Upper Midwest Health Study.

Authors:  Tania Carreón; Mary Ann Butler; Avima M Ruder; Martha A Waters; Karen E Davis-King; Geoffrey M Calvert; Paul A Schulte; Barbara Connally; Elizabeth M Ward; Wayne T Sanderson; Ellen F Heineman; Jack S Mandel; Roscoe F Morton; Douglas J Reding; Kenneth D Rosenman; Glenn Talaska
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.